About Us Portfolio Press Careers Sitemap Advertise Contact Us Make this your Homepage

Custom Search

Register

Sign In

Sign In Using Facebook

Home » Drug News

Intercell Announces Launching of Phase I Clinical Trials of TB Vaccine

December 06, 2007 at 8:52 PM Drug News

Austrian vaccine developer Intercell on Tuesday announced that it has launched Phase I clinical trials of a new preventive tuberculosis vaccine, APA Economics News Service reports. The company is working with the Statens Serum Institut and the Aeras Global TB Vaccine Foundation to develop the vaccine.

Related Links

The vaccine, called HyVac4-IC31, is being tested among individuals who have been vaccinated with the BCG vaccine, according to a release. Trials are taking place at the Karolinska Institutet in Stockholm, Sweden. The experimental vaccine is based on the H4-antigen, which has shown an ability to enhance the BCG vaccine in preclinical trials.

Peter Andersen, vice president for vaccine research and development at SSI, said that as clinical trials begin, the groups are increasing their efforts to "provide the best possible TB vaccine to control the global TB epidemic." According to Alexander von Gabain, Intercell's chief scientific officer, the vaccine's adjuvant, IC31, has "proven to be safe and to induce a strong and sustained immune response that has not yet been seen before in comparable preclinical and clinical vaccine settings."

The vaccine also has "induced more significant protection in a BCG prime-boost regimen than any other vaccine we have tested in the long-term guinea pig challenge model," Jerald Sadoff, president and CEO of Aeras, said.

�

Source-Kaiser Family Foundation
SRM/M

Rehabilitation Centre Helps Disabled Soldiers Learn to 'Live'

Even Human Urine can Be a Good Fertiliser

More News on: AIDS/HIV, Placebo Effects: Rare Insights, Silicosis, Clinical Trials - The Past and The Future , Clinical Trials, Clinical Trials - Different Phases of the trial , Screening Tests for Tuberculosis

Comment & Contribute

Be the first to comment!
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters
	Notify me when reply is posted I agree to the terms and conditions
Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished. Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.

Medwonders Health Network

Support Groups Members Discussions

Total Members - 54995
Support Groups - 445

Health News Index

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Latest News Most Popular Most Commented

Organ Damage in Inflammatory Genetic Disorder Arrested by Rheumatoid Arthritis Drug

Kids' Gadget Perplex 1 In 6 Parents

Immune System Regulation Directly Affected If Raised on a Farm

Shortly, Memory- Impaired Patients to Get Smartphone 'Prescription'

Sporting Activity in Excess Could Mar Long-Term Success of Hip Resurfacing

News Archive
Date :
Category :
Keyword :

News Quick Links

	News Central			Health Watch
	Latest Health News			Health In Focus
	News Category (500+)			Breaking Health News
	Popular News			Celebrating Life
	Health News and Press Release			Medindia - Exclusive
	News Photo Gallery			India Special
	News Video Gallery			Lifestyle and Wellness
	News From Other Resources

Clinical Trials

Complete Medindia Resources

News Categories:


»	Antidepressants and the Risk of Sudden Unexpected Death in Epilepsy

»	Research Says Financial Burden of Prescription Drugs is Dropping

»	New Guidelines to Avoid Heparin Contamination

»	Weight Loss Drug Has Killed At Least 1,300 in France

»	FDA Approves Sanofi�s Treatment for Head Lice
More Drug News

Drug Related News
»	Antidepressants and the Risk of Sudden Unexpected Death in Epilepsy	»	Research Says Financial Burden of Prescription Drugs is Dropping
»	New Guidelines to Avoid Heparin Contamination	»	Weight Loss Drug Has Killed At Least 1,300 in France
»	FDA Approves Sanofi�s Treatment for Head Lice	»	New Scoring Method may Help Decide Who Will Benefit From Stroke Drug
»	New Guidelines Recommend Metformin to Treat Type 2 Diabetes	»	Novel Prostate Cancer Drug Target Identified

Read More >>

Accident and Trauma Care Support Group	Acupuncture Support Group	AIDS/HIV Support Group
Albinism / Hypopigmentation / Albinos Support Group	Alcohol abuse / Alcohol dependence / Alcoholism Support Group	Aromatherapy Support Group
Avian Influenza / Bird Flu Support Group	Ayurveda Support Group	Benign Prostatic Hyperplasia Support Group

Intercell Announces Launching of Phase I Clinical Trials of TB Vaccine

Medwonders Health Network

Drug Related News

Consumers

Medical Professionals

Medical Students

Directories